Zota Health Care Limited IPO
Zota Health Care Ltd manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally. They mainly market generic, patented and OTC pharmaceutical products. Products are marketed in the form of tablets, capsules, ointment, oral liquids, injectable etc as per customers need.
They offer products in various therapeutic categories including liver disorders, osteoarthritis, diabetes, cardiovascular disorders, neurological disorders, psychological disorders, nutritional deficiencies, musculoskeletal disorders, respiratory disorders, antipyretics, and morning sickness during pregnancy.
Zota applied for a patent of 19 unique formulations out of which it already got patent for 6 products and the rest are waiting for approvals. ZHCL has also taken initiatives for digital marketing strategy with a mobile application for its division â€œnutravedic.comâ€ and is in the process of launching another application for easy reach to the end users. ZHCL has also set up a unit at Special Economic Zone Surat, to meet export demands for its products. The company has applied for registration in 15 countries for more than 230 products and has received 46 approvals from 10 countries.
Objects of the Zota Health Care Limited IPO:
Zota Health Care Limited IPO Details:
|Open Date:||Apr 27 2017|
|Close Date:||May 02 2017|
|Face Value:||₹ 10 Per Equity Share|
|Issue Type:||Book Built Issue IPO|
|Issue Size:||58.50 Cr.|
|Lot Size:||1000 Shares|
|Issue Price:||₹ 121-125 Per Equity Share|
|Listing At:||NSE Emerge|
|Listing Date:||May 10 2017|